Transcatheter Valve Therapeutics 2013 Meeting Kicks Off

This post was authored by Xiushui (Mike) Ren, MD, affiliate member of the ACC.. The Transcatheter Valve Therapeutics (TVT) 2013 conference kicked-off yesterday with “The Annual Mad Dash” presentation by Martin Leon, MD, FACC, who summarized the past year of transcatheter aortic valve replacement (TAVR) research in an impressive 20 minutes. According to Leon, there were a total of 835 TAVR manuscripts published in 2012 and 2013. Highlights included: A study by Dr. Vergnat, et al., using 3-D transesophageal echocardiography showing that TAVR resulted in better preserved mitral annular geometry as compared to surgical aortic valve replacement (AVR) Publication of TAVR guidelines by the European Society of Cardiology/ European Association for Cardio-Thoracic Surgery, which gave a Class I recommendation for a Heart Team, availability of on-site cardiac surgery, and for inoperable surgical AVR status; and class IIa indication for high-risk operable surgical AVR status  Formulation of the second generation Valve Academic Research Consortium (VARC-2) definitions  Implementation of the echocardiography core laboratory  Completion of patient enrollment for the Medtronic CoreValve pivotal trial (both extreme and high-risk patients)  German Aortic Valve Registry updates of 13,860 surgical AVR and TAVR patients  Increase in TAVR volume in the US in 2013, including approximately 8000 commercial TAVR procedures through quarter 1 of 2013 and 30...
Source: ACC in Touch Blog - Category: Cardiology Authors: Tags: Clinical Topics CV Meetings Special Topics Source Type: blogs